Logo image of NANO.PA

NANOBIOTIX (NANO.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:NANO - FR0011341205 - Common Stock

17.84 EUR
-0.32 (-1.76%)
Last: 1/23/2026, 7:00:00 PM
Fundamental Rating

1

Overall NANO gets a fundamental rating of 1 out of 10. We evaluated NANO against 86 industry peers in the Biotechnology industry. Both the profitability and financial health of NANO have multiple concerns. NANO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NANO has reported negative net income.
  • In the past year NANO has reported a negative cash flow from operations.
  • NANO had negative earnings in each of the past 5 years.
  • In the past 5 years NANO always reported negative operating cash flow.
NANO.PA Yearly Net Income VS EBIT VS OCF VS FCFNANO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -114.32%, NANO is doing worse than 79.07% of the companies in the same industry.
Industry RankSector Rank
ROA -114.32%
ROE N/A
ROIC N/A
ROA(3y)-79.59%
ROA(5y)-62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NANO.PA Yearly ROA, ROE, ROICNANO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NANO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NANO.PA Yearly Profit, Operating, Gross MarginsNANO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100K -200K -300K -400K -500K

0

2. Health

2.1 Basic Checks

  • NANO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NANO has more shares outstanding
  • Compared to 5 years ago, NANO has more shares outstanding
  • Compared to 1 year ago, NANO has a worse debt to assets ratio.
NANO.PA Yearly Shares OutstandingNANO.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NANO.PA Yearly Total Debt VS Total AssetsNANO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • NANO has an Altman-Z score of -12.97. This is a bad value and indicates that NANO is not financially healthy and even has some risk of bankruptcy.
  • NANO has a Altman-Z score of -12.97. This is in the lower half of the industry: NANO underperforms 76.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.97
ROIC/WACCN/A
WACC7.82%
NANO.PA Yearly LT Debt VS Equity VS FCFNANO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • A Current Ratio of 0.63 indicates that NANO may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.63, NANO is doing worse than 81.40% of the companies in the same industry.
  • A Quick Ratio of 0.63 indicates that NANO may have some problems paying its short term obligations.
  • NANO's Quick ratio of 0.63 is on the low side compared to the rest of the industry. NANO is outperformed by 75.58% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.63
NANO.PA Yearly Current Assets VS Current LiabilitesNANO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

  • NANO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.30%.
  • Looking at the last year, NANO shows a very negative growth in Revenue. The Revenue has decreased by -138.77% in the last year.
EPS 1Y (TTM)-47.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.09%
Revenue 1Y (TTM)-138.77%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%186.77%

3.2 Future

  • Based on estimates for the next years, NANO will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.58% on average per year.
  • The Revenue is expected to grow by 29.13% on average over the next years. This is a very strong growth
EPS Next Y55.91%
EPS Next 2Y19.5%
EPS Next 3Y24.83%
EPS Next 5Y12.58%
Revenue Next Year24.15%
Revenue Next 2Y74.49%
Revenue Next 3Y23.29%
Revenue Next 5Y29.13%

3.3 Evolution

NANO.PA Yearly Revenue VS EstimatesNANO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 100M 200M 300M
NANO.PA Yearly EPS VS EstimatesNANO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NANO. In the last year negative earnings were reported.
  • Also next year NANO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NANO.PA Price Earnings VS Forward Price EarningsNANO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NANO.PA Per share dataNANO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NANO's earnings are expected to grow with 24.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.5%
EPS Next 3Y24.83%

0

5. Dividend

5.1 Amount

  • NANO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NANOBIOTIX / NANO.PA FAQ

What is the fundamental rating for NANO stock?

ChartMill assigns a fundamental rating of 1 / 10 to NANO.PA.


What is the valuation status for NANO stock?

ChartMill assigns a valuation rating of 1 / 10 to NANOBIOTIX (NANO.PA). This can be considered as Overvalued.


What is the profitability of NANO stock?

NANOBIOTIX (NANO.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for NANO stock?

The financial health rating of NANOBIOTIX (NANO.PA) is 0 / 10.